Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Panacos Pharmaceuticals Inc (PANC)
OTHER OTC:PANC
Panacos Pharmaceuticals (PANC) Stock Price & Analysis
7 Followers
PANC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.05
Volume1.00K
Average Volume (3M)N/A
Market Cap
$54.00
Enterprise Value-$8.68M
Total Cash (Recent Filing)$26.89M
Total Debt (Recent Filing)$18.21M
Price to Earnings (P/E)N/A
Beta-17.69
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding53,640,136
10 Day Avg. Volume100
30 Day Avg. VolumeN/A
Standard Deviation43.35
R-Squared0.02
Alpha15.56
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-87.70
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
PANC FAQ
What was Panacos Pharmaceuticals Inc’s price range in the past 12 months?
Currently, no data Available
What is Panacos Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Panacos Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Panacos Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Panacos Pharmaceuticals Inc overvalued?
According to Wall Street analysts Panacos Pharmaceuticals Inc’s price is currently Overvalued.
Does Panacos Pharmaceuticals Inc pay dividends?
Panacos Pharmaceuticals Inc does not currently pay dividends.
What is Panacos Pharmaceuticals Inc’s EPS estimate?
Panacos Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Panacos Pharmaceuticals Inc have?
Panacos Pharmaceuticals Inc has 53,640,000 shares outstanding.
What happened to Panacos Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Panacos Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in PANC
---
Company Description
Panacos Pharmaceuticals Inc
Panacos Pharmaceuticals, Inc. engages in the discovery and development of small-molecule oral drug which is designed to treat human immunodeficiency virus and other major human viral diseases. Its product candidate, bevirimat, which works by a novel mechanism of action called maturation inhibition. The company was founded by Graham Allaway in December 1992 and is headquartered in Watertown, MA.
---
Benitec Biopharma
―
Avid Bioservices
―
Eloxx Pharmaceuticals
―
Cellectar Biosciences
―
---